Seamus Fernandez Recent News
A Pfizer Split Is 'Clearly' On The Table
This Data Signals The End For Merck's Anacetrapib
Novartis Shares Downgraded, Leerink Says 'Consensus Still Way Too High'
Eli Lilly's 2016 Guidance Released Next Week Could Disappoint, Leerink Warns
FDA Approves Allergan's Ozurdex, Rejects Levadex
UPDATE: Leerink Swann Downgrades Sanofi Based on Low Visibility
Fast Money 360: Leerink Swann Is A Buyer Of Merck (MRK)